4th Quarter - Termination
OGR for NOVARTIS SERVICES, INC.
Firm
Client
Income
$30,000
Expenses
—
Terminated
Dec 31, 2015
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.3618, Orphan Drug Fairness Act; issues related to the orphan drug tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN New | Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin |
| CLARENCE ALBRIGHT | — |
| STANTON BULLOCK New | Chief of Staff, Senator Daniel Moynihan |
| CONRAD LASS New | SpcAsst/COS, BLM;LA,Thomas;Asst,Simpson |
| TIMOTHY MCGIVERN | — |
| MOSES MERCADO | — |
| KARISSA WILLHITE | — |
Health Issues HCR
General healthcare, pharmaceutical and Food and Drug Administration (FDA) related issues. S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015; neonatal drug issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN New | Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin |
| CLARENCE ALBRIGHT | — |
| STANTON BULLOCK New | Chief of Staff, Senator Daniel Moynihan |
| CONRAD LASS New | SpcAsst/COS, BLM;LA,Thomas;Asst,Simpson |
| TIMOTHY MCGIVERN | — |
| MOSES MERCADO | — |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.